Pharmaceutical

Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes

The company has fired 25% of staff and discontinued pipeline programs to funnel funds into developing candidates licenced from Sanofi.

Aug 3, 2024 - 04:00
Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes
The company has fired 25% of staff and discontinued pipeline programs to funnel funds into developing candidates licenced from Sanofi.
Read the original article

Tags:

Previous Article

Megamonas bacterium found to influence obesity risk

Next Article

Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Compliance standards in medicines are evolving rapidly. How can CDMOs keep up?  

Compliance standards in medicines are evolving rapidly....

Jun 23, 2023

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Covid-19: Anti-inflammatory drugs do not lead to a swif...

Jul 11, 2023

STAT+: Shareholders elect director’s romantic partner to Biogen’s board

STAT+: Shareholders elect director’s romantic partner t...

Jun 26, 2023